health
May 2, 2026
Report reveals barriers for New EPS cancer patients: critical alerts issued
Oncological patients affiliated with Nueva EPS, an entity intervened by the Government, face waits exceeding 100 days to access vital treatments, according to a report by the Fundación Retorno Vital revealed by Noticias RCN.
TL;DR
- Oncological patients at Nueva EPS face waits over 100 days for vital treatments.
- Critical access barriers include medication delays, unassigned appointments, and authorization issues.
- Patients with breast, lung, prostate, and colon cancer are most affected.
- Delays can range from five to seven months for treatment initiation after diagnosis.
- Some patients have had treatments suspended due to administrative reasons and contract cancellations.
- Nueva EPS has the highest number of complaints regarding attention, opportunity, fragmentation, and continuity of treatments.
- Experts warn that these delays are increasing mortality rates among cancer patients.
- The Fundación Retorno Vital calls for dignified care for high-cost patients, warning of increased metastasis due to lack of timely attention.
- Patients report buying medications out-of-pocket and scheduled surgeries being incomplete due to lack of chemotherapy access.